Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Früh

Showing results (491-500 of 552) with videos related to

Pageof 56
Sort By:
Plos Pathogens|November 10, 2016
Cross-Species Rhesus Cytomegalovirus Infection of Cynomolgus MacaquesBenjamin J Burwitz, Daniel Malouli, Benjamin N Bimber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF CohortOliver Gautschi, Julie Milia, Bastien Cabarrou, et al.
Frontiers in Immunology|July 16, 2026
Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14)Yannik da Silva, Dapi Menglin Chiang, Laura Benecke, et al.
Plos Pathogens|February 22, 2019
Casting a wider net: Immunosurveillance by nonclassical MHC moleculesM Patricia D'Souza, Erin Adams, John D Altman, et al.
BMJ Open|January 27, 2021
Students' top 10 priorities of research uncertainties on students' sleep: a pragmatic James Lind Alliance approachHeidi Holmen, Kirsti Riiser, Borghild Løyland, et al.
The Journal of Clinical Investigation|April 3, 2014
Cytomegalovirus pp65 limits dissemination but is dispensable for persistenceDaniel Malouli, Scott G Hansen, Ernesto S Nakayasu, et al.
Journal for Immunotherapy of Cancer|February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancerAlexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2018
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural MesotheliomaYannis Metaxas, Gareth Rivalland, Laetitia A Mauti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2021
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II TrialSacha I Rothschild, Alfred Zippelius, Eric I Eboulet, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
The pentameric complex is not required for vertical transmission of cytomegalovirus in seronegative pregnant rhesus macaquesHsuan-Yuan Wang, Husam Taher, Craig N Kreklywich, et al.
Pageof 56

Showing results (491-500 of 552) with videos related to

Sort By:
Pageof 56
Plos Pathogens|November 10, 2016
Cross-Species Rhesus Cytomegalovirus Infection of Cynomolgus MacaquesBenjamin J Burwitz, Daniel Malouli, Benjamin N Bimber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF CohortOliver Gautschi, Julie Milia, Bastien Cabarrou, et al.
Frontiers in Immunology|July 16, 2026
Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14)Yannik da Silva, Dapi Menglin Chiang, Laura Benecke, et al.
Plos Pathogens|February 22, 2019
Casting a wider net: Immunosurveillance by nonclassical MHC moleculesM Patricia D'Souza, Erin Adams, John D Altman, et al.
BMJ Open|January 27, 2021
Students' top 10 priorities of research uncertainties on students' sleep: a pragmatic James Lind Alliance approachHeidi Holmen, Kirsti Riiser, Borghild Løyland, et al.
The Journal of Clinical Investigation|April 3, 2014
Cytomegalovirus pp65 limits dissemination but is dispensable for persistenceDaniel Malouli, Scott G Hansen, Ernesto S Nakayasu, et al.
Journal for Immunotherapy of Cancer|February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancerAlexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2018
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural MesotheliomaYannis Metaxas, Gareth Rivalland, Laetitia A Mauti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2021
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II TrialSacha I Rothschild, Alfred Zippelius, Eric I Eboulet, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
The pentameric complex is not required for vertical transmission of cytomegalovirus in seronegative pregnant rhesus macaquesHsuan-Yuan Wang, Husam Taher, Craig N Kreklywich, et al.
Pageof 56